申请人:Senju Pharmaceutical Co., Ltd.
公开号:EP1050308A1
公开(公告)日:2000-11-08
A pharmaceutical composition for preventing or treating visual function disorders caused by ocular circulatory disorders (for example, ocular hypertension and glaucoma) and visual function disorders based on ciliary tension (for example, myopia) whose active component is a vasopressin antagonist.
一种药物组合物,用于预防或治疗由眼部循环障碍(如眼压过高和青光眼)和基于睫状肌紧张的视觉功能障碍(如近视)引起的视觉功能障碍,其活性成分是血管加压素拮抗剂。